http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201491369-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201491369-A1 |
| titleOfInvention | METHOD OF TREATING DIABETES MELLITUS WITH NON-GLYCOLYNED APOLYPOPROTEIN A-IV |
| abstract | Describes methods for treating diabetes of the second type in a subject in need and pharmaceutical compositions for treating diabetes mellitus of the second type, the methods and compositions of the present invention based on the use of non-glycosylated apolipoprotein A-IV, obtained using a protein expression system such as a bacterial expression system . Also disclosed are methods for restoring glucose tolerance in a subject in need to almost normal levels and methods for reducing blood glucose levels in a subject in need based on administering non-glycosylated apolipoprotein A-IV obtained using a protein expression system. |
| priorityDate | 2012-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.